✦ LIBER ✦

Smokeless tobacco use and the risk of Parkinson's disease mortality

✍ Scribed by Eilis J. O'Reilly; Marji L. McCullough; Ann Chao; S. Jane Henley; Eugenia E. Calle; Michael J. Thun; A. Ascherio

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 45 KB
Volume: 20
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.20587

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

We examined the association between smokeless tobacco use and Parkinson's disease (PD) mortality as assessed by death certificate in a prospective cohort of 95,981 never‐smoking men. In this cohort, smokeless tobacco use is inversely associated with PD mortality, with an age‐adjusted risk of 0.22 (0.07–0.67) among current users compared to never users. © 2005 Movement Disorder Society

📜 SIMILAR VOLUMES

Smokeless tobacco use and risk of cancer

Smokeless tobacco use and risk of cancer of the pancreas and other organs

✍ Paolo Boffetta; Bjarte Aagnes; Elisabete Weiderpass; Aage Andersen 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 67 KB 👁 1 views

## Abstract Limited data are available on the carcinogenicity of smokeless tobacco products in organs other than the mouth. Snus is a smokeless tobacco product widely used in Norway. We studied 10,136 Norwegian men enrolled since 1966 in a prospective cohort study, 31.7% of whom were exposed to snu

A case-control study of Parkinson's dise

A case-control study of Parkinson's disease and tobacco use: Gene-tobacco interactions

✍ Giuseppe De Palma; Finlay D. Dick; Stefano Calzetti; Neil W. Scott; Gordon J. Pr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 1 views

A case-control study of genetic, environmental, and occupational risk factors for Parkinson's disease (PD) was carried out in five European countries (Italy, Malta, Romania, Scotland, and Sweden) to explore the possible contribution of interactions among host and environmental factors in sporadic PD

Calcium channel blocker use and risk of

Calcium channel blocker use and risk of Parkinson's disease

✍ Kelly Claire Simon; Xiang Gao; Honglei Chen; Michael A. Schwarzschild; Alberto A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 1 views

## Abstract We investigated whether the use of calcium channel blockers (CCBs) was associated with a reduced risk of Parkinson's disease (PD) in two large prospective cohorts: the Nurses' Health Study (NHS) and Health Professionals' Follow‐Up Study (HPFS). Cox proportional hazards models were used

Nonsteroidal antiinflammatory drug use a

Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease

✍ Honglei Chen; Eric Jacobs; Michael A. Schwarzschild; Marjorie L. McCullough; Eug 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

Reproductive factors, exogenous estrogen

Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease

✍ Kelly Claire Simon; Honglei Chen; Xiang Gao; Michael A. Schwarzschild; Alberto A 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

## Abstract To determine if reproductive factors or exogenous estrogen are associated with risk of Parkinson's disease (PD), we conducted a prospective study with 22 years of follow‐up among postmenopausal participants in the Nurses' Health Study. Relative risks (RRs) and 95% confidence intervals (

Re: “Smokeless tobacco use and risk of c

Re: “Smokeless tobacco use and risk of cancer of the pancreas and other organs” by Boffetta et al.

✍ Lars Ramström 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 44 KB 👁 1 views